…researchers say men account for two-thirds of TB transmission on the continent
By Joseph Erunke, Abuja
Nigeria has emerged as the African country with the widest gap between tuberculosis (TB) infections and cases detected for treatment, raising fresh concerns over the country’s ability to contain the deadly disease, international researchers have warned.
The warning was delivered at a memorial lecture in honour of Lovette Lawson and Luis Cuevas, organised by the Zankli Research Institute of Bingham University, where experts highlighted the urgent need to close diagnostic gaps, improve access to healthcare and strengthen community-based screening.
Delivering the keynote address at the event on Wednesday, Professor Bertie Squire, Deputy Pro-Vice-Chancellor for Partnerships at the Liverpool School of Tropical Medicine, United Kingdom, said Nigeria recorded the continent’s highest gap between the estimated number of people living with TB and those officially notified and placed on treatment.
Squire also disclosed that men accounted for about two-thirds of TB transmission across Africa, warning that undetected and untreated infections were sustaining the epidemic and exposing more people to the disease.
He identified men, people living in poverty, rural and peri-urban communities, people living with HIV and children as particularly vulnerable groups requiring targeted interventions to improve early diagnosis and treatment.
The lecture, held as part of activities marking the 10th anniversary of the Zankli Research Institute, celebrated Lawson’s contributions to TB research and the development of diagnostic facilities that have supported efforts to improve the detection and management of the disease.
Squire said the challenge was not merely developing better diagnostic technologies but ensuring that people with TB could access them early enough to receive treatment and prevent further transmission.
According to him, the research legacy of Lawson and his collaborators has helped shape international approaches to TB diagnosis, particularly in resource-constrained settings where financial hardship and weak diagnostic infrastructure often prevent patients from accessing timely care.
He explained that conventional TB diagnostic procedures once required patients to submit multiple sputum samples over several days, forcing many to make repeated visits to health facilities.
Although the tests were relatively simple, the process imposed substantial financial and social burdens on patients, particularly those living in poverty.
Squire cited research showing that poorer patients in Malawi incurred costs exceeding twice their monthly income while seeking a TB diagnosis, largely because of indirect expenses and lost opportunities to work or care for their families.
He said the findings helped drive research into simpler diagnostic procedures that could reduce the number of hospital visits without compromising accuracy.
One major breakthrough, he explained, was evidence that collecting two sputum specimens on the same day could achieve diagnostic accuracy comparable to the conventional approach of collecting three specimens over several days.
The findings helped inform changes in diagnostic guidelines, reducing the burden on patients and improving access to testing.
He also highlighted research demonstrating the benefits of light-emitting diode (LED) fluorescence microscopy, which improved the detection of TB bacteria and contributed to global recommendations supporting its use in diagnostic services.
Squire said these advances illustrated the importance of research that responds directly to the realities of patients, particularly those who face barriers to accessing healthcare.
He further explained that the establishment of a TB reference laboratory was a major milestone in the development of Zankli’s research capacity, as Nigeria previously lacked the necessary laboratory infrastructure to provide a reference standard for evaluating diagnostic tests.
A TB culture laboratory, he noted, requires specialised expertise and painstaking procedures because the bacteria grow slowly and must be monitored under controlled conditions over several weeks or months.
The laboratory established through the collaborative efforts of researchers later moved to the Zankli Research Institute, providing a foundation for further studies and the evaluation of newer diagnostic technologies.
Squire said molecular diagnostic tools had since significantly improved the prospects of detecting TB, with some cartridge-based tests capable of producing results in approximately 45 minutes to one hour.
Such technologies, he added, could achieve sensitivity levels in the 90 per cent range, compared with the roughly 60 per cent sensitivity associated with earlier microscopy-based approaches.
However, he cautioned that the global TB response continued to face significant challenges because many infected people were still being missed before they could be diagnosed and placed on treatment.
He said the consequences extended beyond individual patients to entire communities, as undetected infections could progress to severe illness or death while allowing continued transmission.
Squire also drew attention to the Light Consortium, an international research collaboration involving Nigeria, Uganda, Kenya and Malawi, alongside institutions in the United Kingdom.
The consortium, he explained, has explored ways of improving TB detection among men through community engagement, male champions and mobile chest X-ray screening.
Research conducted with the participation of Zankli researchers found that male champions promoting mobile X-ray services were feasible and acceptable to communities, while helping improve TB knowledge and reduce stigma.
He stressed that trusted partnerships involving national TB programmes, government ministries, academic institutions and local communities were essential to translating research findings into practical improvements in healthcare.
The keynote speaker also highlighted the Start4All research consortium, which is examining combinations of screening and diagnostic tests to identify people with TB who are currently being missed by existing health systems.
He said researchers increasingly recognised that no single test was likely to solve every diagnostic challenge in the immediate future, making it necessary to develop combinations of tools that were accurate, affordable and accessible.
According to him, the ultimate goal must be to ensure that scientific discoveries produce measurable benefits for patients, particularly those who are most disadvantaged.
Welcoming participants, Vice-Chancellor of Bingham University, Prof. Haruna Kuje Ayuba, described the late Prof. Lawson as a scientist, mentor and visionary whose contributions were central to the development of the Zankli Research Institute.
Ayuba said Lawson understood that meaningful scientific research required more than ideas, stressing the importance of commitment, collaboration and the facilities necessary to support discovery.
He said the laboratory Lawson helped establish was not merely a physical structure but represented a belief in the ability of scientific research to address public health challenges and improve lives.
According to the vice-chancellor, the institute’s progress over the past decade reflected the foresight and determination of individuals who invested in building institutions whose full potential might only become evident long after their time.
He urged researchers and university management to sustain Lawson’s legacy by strengthening research infrastructure, promoting mentorship and creating opportunities for younger scientists to contribute to solving societal problems.
Ayuba commended the Director of the Zankli Research Institute, Associate Professor John Bimba, and his team for organising the memorial lecture as part of the institute’s 10th-anniversary activities.
He also acknowledged Lawson’s family, staff, students and researchers whose contributions had helped preserve and advance his work.
Earlier, Bimba said the memorial lecture was intended not only to honour Lawson and other pioneering researchers but also to expose younger academics and students to the achievements that had shaped the institute’s development.
He described Lawson and his collaborators as mentors whose guidance had broadened his understanding of public health research and strengthened his professional development.
Bimba said the event was deliberately organised to encourage undergraduate students and researchers from other faculties to appreciate the institute’s history and understand the importance of building on the achievements of previous generations.
He urged participants to reflect on the institute’s past while considering the opportunities and responsibilities confronting the next generation of researchers.
According to him, the future of Zankli Research Institute would depend largely on how effectively it nurtured young scientists and equipped them to sustain its research mission.
He expressed appreciation to the university management, the institute’s partners and Lawson’s family for their support, particularly in sustaining the institution’s research activities.
The memorial lecture underscored the continuing importance of international research partnerships in tackling infectious diseases and the need to ensure that scientific advances translate into affordable diagnostic services and better health outcomes for Nigerians.
It also renewed attention to Lawson’s contribution to building research capacity at Zankli, with participants urged to sustain his commitment to scientific innovation, mentorship and public service.

No comments yet. Start the conversation.